Abstract

An attempt was made to improve the release property of nifedipine (NP) from Witepsol® H-15, glycerin and polyethylene glycol (PEG) suppository bases by means of the complexation with 2-hydroxypropyl-β-cyclodextrin (HP-β-CyD). The amorphous complexes of NP with HP-β-CyD in molar ratios of 1:1–1:10 (guest:host) were prepared by the spray-drying method. The NP/HP-β-CyD complex was homogeneously dispersed in Witepsol® H-15 suppository base, whereas the drug alone and the physical mixture of the guest and host were sedimented at the bottom of the base. The release rates of NP from Witepsol® H-15 and glycerin suppositories were significantly increased by the complexation with HP-β-CyD. On the other hand, HP-β-CyD gave negligible effect on the release rate of NP from PEG suppository base. The results indicated that Witepsol® H-15 suppository containing NP/HP-β-CyD complex is useful from a viewpoint of the release control and quality assurance.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.